Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study

Overview of attention for article published in BMC Cardiovascular Disorders, August 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 177 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 542 followers.

Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study | BMC Cardiovascular Disorders | Full Text https://t.co/aBlGPWNkw7

20 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.